Evaluation Study of SPOTme® Skin Cancer Screenings
- Conditions
- Skin Cancer
- Interventions
- Behavioral: Intervention ArmOther: AAD SPOTmeⓇ skin cancer screening
- Registration Number
- NCT03564769
- Lead Sponsor
- Harvard School of Public Health (HSPH)
- Brief Summary
This study evaluates the impact of the AAD SPOTme® skin cancer screening events on attendees' skin cancer prevention and detection behaviors. This study will also evaluate whether an educational intervention will improve post-screening engagement of attendees with dermatologists.
- Detailed Description
Despite tremendous growth in both the interest and volume of skin cancer screenings at the national level, the actual utility and impact of the AAD SPOT me™ skin cancer screening programs have not been fully evaluated. This study will address this knowledge gap. Early detection is vital in the fight against skin cancer, the most common cancer in the United States. While the effects of skin cancer can be devastating, this disease is highly treatable when detected early.
This study evaluates the impact of the AAD SPOTme® skin cancer screening events on attendees' skin cancer prevention and detection behaviors. This study will also evaluate whether an educational intervention will improve post-screening engagement of attendees with dermatologists.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 431
- Participated in the American Academy of Dermatology national screening program in 2016 or 2017
- Have a presumptive diagnosis (screening, non-confirmed) of melanoma
- Have provided the AAD with permission to be re-contacted
- Have provided the AAD with an email address
- Aged 18 years or older
- Able to read English
- None
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention Arm 1 Intervention Arm Individuals randomized to intervention group 1 will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017 AND will receive additional skin cancer screening educational materials. Intervention Arm 1 AAD SPOTmeⓇ skin cancer screening Individuals randomized to intervention group 1 will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017 AND will receive additional skin cancer screening educational materials. Intervention Arm 2 AAD SPOTmeⓇ skin cancer screening Individuals randomized to intervention group 2 will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017 only.
- Primary Outcome Measures
Name Time Method Completion of a physician skin examination Baseline Self-report of a physician skin examination will be defined as a health care provider examining the patient's entire body for any sign of skin cancer during the period following patient's receipt of an AAD SPOTme® skin cancer screening to the baseline assessment.
- Secondary Outcome Measures
Name Time Method Patient thorough skin self-examination (TSSE) 6 months Self-report of patient thorough skin self-examination (TSSE) will be defined as performing at least one TSSE during the 3 months prior to the 6-month follow up assessment
Completion of a physician skin examination 6 months Self-report of a physician skin examination will be defined as a health care provider examining the patient's entire body for any sign of skin cancer during the 3 months prior to the 6-month follow up assessment
Patient attitude towards sun protection 6 months Self-report of patient attitude towards use of sun protection will be defined by likelihood of engaging in sun protection practices in the year following the 6-month follow up assessment
Trial Locations
- Locations (1)
Harvard TH Chan School of Public Health
🇺🇸Boston, Massachusetts, United States